The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

This momentum is further supported by the continued growth in Skytrofa sales, which, despite currently holding a small market share, has ample room for expansion. Additionally, the upcoming ...

Goldman Sachs analysts remain positive about the early launch metrics for Yorvipath and its commercial prospects, which they believe could alleviate concerns regarding the performance of Skytrofa.

The company’s commitment to advancing their pipeline, including potential US filings for TransCon CNP and expanding Skytrofa’s label, supports a favorable long-term growth trajectory ...

Investing.com -- Shares of Ascendis Pharma (NASDAQ:ASND) fell 1% after the company provided its full-year guidance for Skytrofa revenue, which fell short of the average analyst expectations. During ...

Investing.com -- Shares of Ascendis Pharma (NASDAQ:ASND) fell 1% after the company provided its full-year guidance for Skytrofa revenue, which fell short of the average analyst expectations.

“Ascendis is well-positioned for rapid revenue growth with the launch of our first two Endocrinology Rare Disease medicines, SKYTROFA and YORVIPATH, and, following our pre-NDA meeting, planned ...

charts in the U.K. this week, but oddly, there's no crossover. LOS ANGELES, CALIFORNIA - NOVEMBER 01: Harry Styles attends the Los Angeles Premiere of "My Policeman" at Regency Bruin Theatre on ...

"Ozempic is the only version among the weekly injectables — Ozempic, Wegovy, Zepbound and Mounjaro — that has the option to ‘hack’ the pen for a smaller dose," Dr. Alexandra Sowa ...

India lost the fifth Test against Australia in Sydney, resulting in a 3-1 series defeat. With that, India also missed the World Test Championship final qualification. Yashasvi Jaiswal stood out ...

Elvis Presley earns his second No. 1 on Billboard's Top Rock Albums chart as The Classic Christmas ... [+] Album finally hits the top spot years after its release. BURBANK, CA - JUNE 27 ...

Ed Sheeran secures his eighth Number 1 album with +–=÷× (Tour Collection). In its 14th week on chart, having made its debut in October 2024, the collection lifts seven to finally reach the ...